NYSE:USNA', 'USANA Health Sciences Inc.', 'http://finnewsdaily.com/finnews.png');

How Many USANA Health Sciences, Inc. (NYSE:USNA)’s Analysts Are Bearish?

December 8, 2017 - By Marie Mckinney

 How Many USANA Health Sciences, Inc. (NYSE:USNA)'s Analysts Are Bearish?
Investors sentiment increased to 1.47 in Q2 2017. Its up 0.10, from 1.37 in 2017Q1. It is positive, as 21 investors sold USANA Health Sciences, Inc. shares while 32 reduced holdings. 21 funds opened positions while 57 raised stakes. 10.64 million shares or 7.29% more from 9.92 million shares in 2017Q1 were reported.
Voya Investment Mgmt Ltd Liability stated it has 5,712 shares. Great West Life Assurance Can stated it has 1,054 shares. Globeflex Capital Lp reported 0.36% stake. Sg Americas Lc holds 0% of its portfolio in USANA Health Sciences, Inc. (NYSE:USNA) for 2,520 shares. Pub Employees Retirement Sys Of Ohio has invested 0% of its portfolio in USANA Health Sciences, Inc. (NYSE:USNA). Federated Pa reported 0% stake. Lsv Asset Management has 21,211 shares for 0% of their portfolio. Hsbc Public Ltd has 18,040 shares for 0% of their portfolio. Moreover, Bancorporation Of New York Mellon Corporation has 0% invested in USANA Health Sciences, Inc. (NYSE:USNA) for 90,193 shares. Moreover, Phocas has 0.83% invested in USANA Health Sciences, Inc. (NYSE:USNA). 3,618 are held by Citadel Advsrs Lc. Rothschild Asset Mngmt invested 0.02% in USANA Health Sciences, Inc. (NYSE:USNA). Shell Asset Mgmt owns 6,542 shares or 0.01% of their US portfolio. Credit Suisse Ag holds 8,771 shares. State Street Corporation reported 0% stake.

USANA Health Sciences, Inc. (NYSE:USNA) Ratings Coverage

Among 3 analysts covering USANA Health Science (NYSE:USNA), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. USANA Health Science had 9 analyst reports since August 6, 2015 according to SRatingsIntel. Pivotal Research upgraded USANA Health Sciences, Inc. (NYSE:USNA) rating on Wednesday, August 5. Pivotal Research has “Hold” rating and $200.0 target. The rating was upgraded by Sidoti on Friday, October 16 to “Buy”. Pivotal Research downgraded USANA Health Sciences, Inc. (NYSE:USNA) on Monday, May 1 to “Hold” rating. As per Wednesday, October 25, the company rating was maintained by Pivotal Research. The firm has “Buy” rating by DA Davidson given on Wednesday, September 16. The stock of USANA Health Sciences, Inc. (NYSE:USNA) has “Buy” rating given on Wednesday, February 8 by Pivotal Research. The rating was downgraded by DA Davidson on Thursday, August 6 to “Neutral”. Below is a list of USANA Health Sciences, Inc. (NYSE:USNA) latest ratings and price target changes.

25/10/2017 Broker: Pivotal Research Rating: Buy Old Target: $70.00 New Target: $80.00 Maintain
26/07/2017 Broker: Pivotal Research Rating: Buy New Target: $70.0000

The stock decreased 0.56% or $0.4 during the last trading session, reaching $70.75. About 112,503 shares traded or 3.10% up from the average. USANA Health Sciences, Inc. (NYSE:USNA) has risen 6.87% since December 8, 2016 and is uptrending. It has underperformed by 9.83% the S&P500.

USANA Health Sciences, Inc. develops, makes, and sells science nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company has market cap of $1.70 billion. The firm offers USANA Nutritionals Essentials product line, which includes vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It has a 18.38 P/E ratio. It also provides Sensé—beautiful science products, such as personal care products that support healthy skin and hair through topical nourishment, moisturization, and protection; and other products for prenatal, infant, and young child age groups.

More notable recent USANA Health Sciences, Inc. (NYSE:USNA) news were published by: Seekingalpha.com which released: “USANA Health Sciences: Strong Moat, Highly Profitable And Growing Sales” on June 08, 2017, also Marketwatch.com with their article: “USANA Health Sciences shares drop after company misses earnings, cuts outlook” published on July 25, 2017, Seekingalpha.com published: “USANA Health Sciences’ (USNA) CEO David Wentz on Q4 2016 Results – Earnings …” on February 08, 2017. More interesting news about USANA Health Sciences, Inc. (NYSE:USNA) were released by: Nasdaq.com and their article: “Earnings Reaction History: USANA Health Sciences Inc., 60.0% Follow-Through …” published on October 24, 2017 as well as Seekingalpha.com‘s news article titled: “USANA Health Sciences’ (USNA) CEO Kevin Guest on Q1 2017 Results – Earnings …” with publication date: May 03, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.